Skip to main content
OpenTrials
Completed

NCT Number: NCT03875274

Morphine Added to Ropivacaine for FICB for Postoperative Analgesia

prospective, randomized double blinded study to investigate the effects of morphine as an adjuvant to ropivacaine on FICB

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Pain Neurologic Manifestations Pain Pain, Postoperative Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

BPKIHS

Dharān, Sunsari, 977, Nepal

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients undergoing elective femur surgery under spinal anaesthesia
  • Age group (18-65 years)
  • ASA physical status I and II

Exclusion criteria

  • • Not willing to participate in the study
  • Other painful co-morbidities (neuropathies)
  • Allergy or any contraindication to study medication
  • Psychiatric disorder
  • Coagulopathy
  • Infection at the site of the block
  • Use of other modes of anaesthesia or analgesia besides spinal anaesthesia.

Treatment and study plan

Ropivacaine, Morphine

Drug

Morphine added to ropivacaine for fascia iliaca compartment block

Ropivacaine, Saline

Drug

Normal saline added to ropivacaine for fascia iliaca compartment block

Primary outcomes

  1. Duration of Analgesia

    Time frame: 24 hours

    The period in minutes when the patient is free of pain

Sponsors and collaborators

Lead sponsor

B.P. Koirala Institute of Health Sciences

Other

Registry information

Official study title

Postoperative Analgesic Effect of Morphine Added to Ropivacaine for Fascia Iliaca Compartment Block Following Femoral Fracture Surgeries

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Mar 14, 2019
Registry last updated
Mar 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.